Senior Scientist, Discovery Oncology
Bristol Myers Squibb
Summary
The Discovery Oncology Department within the Protein Homeostasis Thematic Research Center (PH TRC) is focused on discovering and developing novel therapeutics by leveraging targeted protein degradation and other innovative approaches to modulate disease-relevant biology. We are seeking a highly motivated Senior Scientist with expertise in hematological malignancies, particularly Acute Myeloid Leukemia (AML), and experience in drug discovery research.
Job description
Position Summary
The Discovery Oncology Department within the Protein Homeostasis Thematic Research Center (PH TRC) is focused on discovering and developing novel therapeutics by leveraging targeted protein degradation and other innovative approaches to modulate disease-relevant biology. We are seeking a highly motivated Senior Scientist with expertise in hematological malignancies, particularly Acute Myeloid Leukemia (AML), and experience in drug discovery research.
The successful candidate will work in a multidisciplinary environment to:
- Drive the biological validation of novel therapeutic targets in hematological malignancies.
- Develop and implement robust cellular and molecular assays to support drug discovery programs.
- Design and execute mechanistic studies that advance our understanding of target biology, compound mechanism of action, mechanisms of resistance, biomarker strategies, and disease positioning.
- Contribute to the development of translational hypotheses to support the progression of discovery programs toward clinical development.
This role requires a Senior Scientist capable of independently designing and executing experimental strategies, interpreting complex datasets, and influencing project team decisions. The successful candidate will work closely with chemistry, computational biology, bioinformatics, translational development, and other functional groups to advance innovative therapeutic programs towards the clinic.
Position Responsibilities
- Independently design, execute, analyze, and interpret experiments to support target validation and drug discovery programs.
- Develop and implement cellular, molecular, and biochemical assays to evaluate novel therapeutic hypotheses.
- Design and conduct mechanistic studies in cancer cell biology, molecular biology, cellular biochemistry, and targeted protein degradation.
- Utilize hematological disease models to investigate target biology, compound mechanism of action, resistance mechanisms, and biomarker strategies.
- Collaborate closely with chemistry, bioinformatics, screening, and translational research teams to advance project objectives.
- Integrate genomic, transcriptomic, proteomic, and functional datasets to generate actionable biological insights.
- Lead scientific projects, initiatives and drive complex workstreams within multidisciplinary project teams.
- Clearly communicate scientific findings through presentations, reports, publications, and project team discussions.
- Mentor junior scientists and contribute to a collaborative and scientifically rigorous research environment.
- Maintain accurate documentation and ensure delivery of high-quality data in a timely manner.
Basic Qualifications
- Bachelor's Degree 7+ years of academic and/or industry experience or Master's Degree 5+ years of academic and/or industry experience or Ph.D. or equivalent advanced degree in the Life Sciences 2+ years of academic and/or industry experience
Preferred Qualifications
- PhD in Cancer Biology, Cell Biology, Hematology, or a related discipline with 3-6 years of relevant drug discovery experience, or MS/BS with equivalent industry experience and demonstrated scientific leadership in drug discovery.
- Strong expertise in hematological malignancies, particularly Acute Myeloid Leukemia (AML); experience in other hematological malignancies is desirable.
- Deep understanding of cancer biology, including disease genetics, transcriptional regulation, epigenetics, differentiation state biology, and mechanisms of therapeutic response and resistance.
- Track record of applying disease biology insights to target validation, mechanism-of-action studies, and biomarker strategies for hematological malignancies.
- Extensive hands-on experience with mammalian cell culture and molecular and cellular biology techniques, including flow cytometry, CRISPR/Cas9 gene editing, lentiviral approaches, western blotting, JESS, HiBiT assays, and functional cellular assays.
- Experience designing and executing colony formation (CFU), proliferation, apoptosis, differentiation, and cell-cycle assays.
- Demonstrated ability to independently drive scientific questions and translate findings into discoveries that advance drug discovery programs.
- Experience identifying and evaluating pharmacodynamic biomarkers and translational strategies to support advancement of drug discovery programs.
- Experience with targeted protein degradation, molecular glues, or E3 ligase biology is highly desirable.
- Proficiency with scientific data analysis tools including GraphPad Prism, FlowJo, Microsoft Excel, and PowerPoint.
- Excellent written and verbal communication skills, with the ability to effectively present scientific concepts and influence cross-functional teams.
- Demonstrated ability to thrive in a fast-paced, highly collaborative drug discovery environment.
Requirements
- Bachelor's Degree with 7+ years of academic and/or industry experience, or Master's Degree with 5+ years, or Ph.D. or equivalent advanced degree in the Life Sciences with 2+ years
- Expertise in hematological malignancies, particularly Acute Myeloid Leukemia (AML)
- Experience in drug discovery research
- Deep understanding of cancer biology including disease genetics, transcriptional regulation, epigenetics, and mechanisms of therapeutic response and resistance
- Hands-on experience with mammalian cell culture and molecular and cellular biology techniques including flow cytometry, CRISPR/Cas9 gene editing, lentiviral approaches, western blotting, JESS, HiBiT assays, and functional cellular assays
- Experience designing and executing colony formation (CFU), proliferation, apoptosis, differentiation, and cell-cycle assays
- Ability to independently drive scientific questions and translate findings into discoveries
- Experience identifying and evaluating pharmacodynamic biomarkers and translational strategies
- Proficiency with GraphPad Prism, FlowJo, Microsoft Excel, and PowerPoint
- Excellent written and verbal communication skills
- Ability to thrive in a fast-paced, highly collaborative drug discovery environment
Benefits
- Wellbeing Support
- Retirement Benefits
- Financial Protection Benefits
- Medical, Dental & Vision
- Life & Disability Insurance
- Flexible Time Off
- 11 Paid Company Holidays
- Paid Sick Leave
- Volunteer Days
- Summer Hours Flexibility
- Global Shutdown
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.